Israel’s DreaMed Diabetes said on Monday the U.S. Food and Drug Administration has approved for marketing its Advisor Pro software to help manage diabetes treatment.
Read more on Reuters here.
[DreaMed in Reuters] Israel’s DreaMed gets FDA ok for diabetes management software
![[DreaMed in Reuters] Israel’s DreaMed gets FDA ok for diabetes management software](https://blog.ourcrowd.com/wp-content/uploads/2017/11/reuters-NEW.jpg)
![[Axiom Space in Yahoo News] Upcoming Axiom Space Mission to Include Woman Commander and Two Saudi AstronautsNASA clears Axiom Space’s 2nd private astronaut mission to ISS](https://blog.ourcrowd.com/wp-content/uploads/2021/02/yahoo-news.png)
![[Zebra in Forbes] The Tel Aviv Tech Startups To Watch In 2018](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
![[SaNOtize in Economic Times] Glenmark inks deal with SaNOtize for COVID treatment spray in India, other Asian markets](https://blog.ourcrowd.com/wp-content/uploads/2019/05/economic-times-new.jpg)
![[Maniv in Israel21c] Meet the specialists – Israel’s newest generation of VCs](https://blog.ourcrowd.com/wp-content/uploads/2017/10/israel-21cNEW-1.jpg)
